Journalism of Courage
Advertisement
Prabha Raghavan
Authors you can follow
More From Prabha Raghavan - Page 4
Bengaluru-based Stelis Biopharma to make 200 million doses of Sputnik V Covid vaccineSubscriber Only
March 19, 2021 16:20 IST
Stelis is the fourth Indian company to partner with RDIF for Sputnik V and will be the third manufacturer of the Russian vaccine here.
Fri, Mar 19, 2021
Explained: The Covid-19 vaccines India is making, testing and supplyingSubscriber Only
March 19, 2021 04:26 IST
At a time supplies of vaccines around the world could take a hit due to instances of vaccine and raw material nationalism, the question is whether the existing supplies will be enough to cover the requirements of India and the other countries relying on these shots going forward.
Fri, Mar 19, 2021Gland Pharma to join Sputnik V productionSubscriber Only
March 17, 2021 04:52 IST
The agreement is expected to boost India’s capacity to manufacture this vaccine to around 350 million doses a year.
Wed, Mar 17, 2021
Clots concern around AstraZeneca shot: Top monitoring body will look at data on vaccine side effectsSubscriber Only
March 15, 2021 22:57 IST
A preliminary review conducted towards the end of last week prima facie reflected no cause for concern, according to the head of one of the Covid-19 task forces of the Indian Council of Medical Research (ICMR).
Tue, Mar 16, 2021
Covaxin off clinical trial mode, to have same authorisation as SII’s CovishieldSubscriber Only
March 12, 2021 03:57 IST
The development, which follows recommendations of an expert panel under the regulator, means Covaxin will now have the same authorisation as Serum Institute of India’s Covishield.
Fri, Mar 12, 2021
IT Min steps up cyberattack vigil, asks companies to raise defenceSubscriber Only
March 12, 2021 03:49 IST
The exercise was initiated towards the end of last year over triggers like rising potential cyber threats from countries like China, Russia and Uzbekistan, according to the executive.
Fri, Mar 12, 2021
Clinical trial mode: Restrictive label that Covaxin is set to shedSubscriber Only
March 11, 2021 04:35 IST
The “clinical trial mode” label meant Bharat Biotech had to seek informed consent prior to giving Covaxin to those eligible for the government’s vaccination drive.
Thu, Mar 11, 2021
Covaxin boost: SEC says drop clinical trial mode labelSubscriber Only
March 11, 2021 01:20 IST
The recommendations have been sent to the Drugs Controller General of India (DCGI) for consideration. If the vaccine is taken off clinical trial mode then the beneficiaries will no longer have to sign a consent form for taking the jab.
Thu, Mar 11, 2021
Bordering nation FDIs: Final call with ministriesSubscriber Only
March 10, 2021 03:06 IST
An inter-ministerial committee formed to scrutinise these proposals does not decide on approvals to these FDI proposals, for which government approval was made mandatory in April 2020.
Wed, Mar 10, 2021
RS Sharma: ‘Plan is for a demand-driven Covid vaccine registration system with hospitals nearby’Subscriber Only
March 09, 2021 03:47 IST
The system is running smoothly. It is a very good system where people have the flexibility to register, people have the flexibility to schedule (and) reschedule appointments and go there and get (vaccinations) done.
Mon, Mar 08, 2021
Non-basmati rice exports surge as West Asia, Africa build reservesSubscriber Only
March 07, 2021 01:13 IST
Shipments of the staple food grain between April 2020 and January 2021 more than doubled over the same period in the previous financial year, showed provisional government data.
Sun, Mar 07, 2021
‘Informal system’ run by some private hospitals, no timely schedule: NHA CEOSubscriber Only
March 05, 2021 03:11 IST
RS Sharma. Terming it a “worrying” trend, he said the government is gearing up to take action against those who do not “rectify” this.
Fri, Mar 05, 2021
Bharat Biotech’s Covaxin has around 81% efficacy: What does this mean for India?Subscriber Only
March 03, 2021 19:14 IST
Bharat Biotech's Covaxin efficacy: Covaxin is one of the two vaccines being used in India’s mass vaccination programme. The promising findings on efficacy are expected to add value to the vaccine and ease hesitancy related to it.
Thu, Mar 04, 2021
Explained: China’s cyber eye and IndiaSubscriber Only
March 03, 2021 04:30 IST
In the latest in a series of surveillance and hacking attempts, a Chinese state-backed hacker firm has been reported to be targeting Indian vaccine makers. Why is this happening, and what are the implications?
Thu, Mar 04, 2021
Maharashtra minister suggests foreign hack in Mumbai outageSubscriber Only
March 02, 2021 04:41 IST
US firm says blackout a China message; Centre confirms alert, says no data loss
Tue, Mar 02, 2021
Explained: In a tense year, India-China trade stayed robustSubscriber Only
February 27, 2021 05:57 IST
China got back to the top of India's trade partners' list in a year in which armies of the two countries remained locked in a tense standoff in eastern Ladakh.
Sat, Feb 27, 2021
Covid vaccination: Geared up for next phase, private hospitals await claritySubscriber Only
February 27, 2021 01:40 IST
“We're waiting clarity from the government on the number of vaccines they'll give us. Once we get that (clarity), we intend to start with 15,000 vaccinations on day one and keep ramping up as required,” said Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Enterprise Ltd.
Sat, Feb 27, 2021
Tests on children: Expert panel asks Bharat Biotech to submit Covaxin efficacy dataSubscriber Only
February 25, 2021 05:36 IST
Bharat Biotech’s Covaxin received restricted use approval in an emergency situation on January 3 for use in those aged above 18. So far, the vaccine has been administered to healthcare and frontline workers “in clinical trial mode”.
Thu, Feb 25, 2021
Rs 7,325-crore PLI scheme to cover laptops, PCs, serversSubscriber Only
February 24, 2021 17:05 IST
The approval of PLI scheme for these hi-tech IT hardware gadgets comes after the Cabinet last week cleared a Rs 12,195 crore scheme for telecom equipment manufacturing.
Thu, Feb 25, 2021
Covaxin efficacy data in two weeks: Bharat BiotechSubscriber Only
February 23, 2021 01:52 IST
This would be the first time that the company would be able to provide clarity on how many symptomatic cases of Covid-19 its indigenous vaccine can prevent.
Tue, Feb 23, 2021
Phase 3 trials almost over, Dr Reddy’s seeks emergency use nod for Sputnik VSubscriber Only
February 20, 2021 04:53 IST
As part of the review process, DRL said it will present the safety profile of the phase 2 study conducted on Sputnik V as well as interim data of its ongoing phase 3 study, which it is expected to complete by February 21.
Sat, Feb 20, 2021
Explained: What Sputnik V’s emergency use application may mean for IndiaSubscriber Only
February 19, 2021 20:36 IST
Dr Reddy’s Laboratories has approached India's apex drug regulatory body for emergency approval of Sputnik V. The Indian Express looks at what this would mean for the country and its vaccination campaign against Covid-19.
Sun, Feb 21, 2021
Explained: Is discovery of the South African Covid-19 variant in India a matter of concern?Subscriber Only
February 16, 2021 20:04 IST
South Africa variant of Covid-19: What is this new strain and what does this mean for India's efforts to vaccinate its population against the novel coronavirus?
Mon, Feb 22, 2021
Uttarakhand: In terrain dotted with hydro projects, flood hits severalSubscriber Only
February 08, 2021 04:30 IST
Sources said that while the civil structure survived the flood, at least a couple of gates of the spillway have been swept away. A boring machine was stuck inside a tunnel of the run-of-river plant, they said.
Mon, Feb 08, 2021
Explained: Why has Pfizer’s vaccine application for India been turned down for now?Subscriber Only
February 05, 2021 16:03 IST
The Subject Expert Committee under CDSCO that looked into Pfizer's proposal and presentation did not recommend that the Drug Controller General of India (DCGI) approve the application at present.
Sat, Feb 06, 2021Journalism of Courage
Install the Express App for
a better experience
a better experience
Featured
Trending Topics
News
Multimedia
Follow Us